Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3′- digallate (TF3)

Chia Nan Chen, Coney P.C. Lin, Kuo Kuei Huang, Wei Cheng Chen, Hsin Pang Hsieh, Po Huang Liang, John T.A. Hsu

Research output: Contribution to journalArticlepeer-review

171 Citations (Scopus)


SARS-CoV is the causative agent of severe acute respiratory syndrome (SARS). The virally encoded 3C-like protease (3CLPro) has been presumed critical for the viral replication of SARS-CoV in infected host cells. In this study, we screened a natural product library consisting of 720 compounds for inhibitory activity against 3CLPro. Two compounds in the library were found to be inhibitive: tannic acid (IC50 = 3 μM) and 3-isotheaflavin-3-gallate (TF2B) (IC50 = 7 μM). These two compounds belong to a group of natural polyphenols found in tea. We further investigated the 3CLPro-inhibitory activity of extracts from several different types of teas, including green tea, oolong tea, Puer tea and black tea. Our results indicated that extracts from Puer and black tea were more potent than that from green or oolong teas in their inhibitory activities against 3CLPro. Several other known compositions in teas were also evaluated for their activities in inhibiting 3CLPro. We found that caffeine, (-)-epigallocatechin gallte (EGCg), epicatechin (EC), theophylline (TP), catechin (C), epicatechin gallate (ECg) and epigallocatechin (EGC) did not inhibit 3CLPro activity. Only theaflavin-3,3′-digallate (TF3) was found to be a 3CLPro inhibitor. This study has resulted in the identification of new compounds that are effective 3CLPro inhibitors.

Original languageEnglish
Pages (from-to)209-215
Number of pages7
JournalEvidence-based Complementary and Alternative Medicine
Issue number2
Publication statusPublished - 2005 Jun

All Science Journal Classification (ASJC) codes

  • Complementary and alternative medicine


Dive into the research topics of 'Inhibition of SARS-CoV 3C-like protease activity by theaflavin-3,3′- digallate (TF3)'. Together they form a unique fingerprint.

Cite this